Abide Therapeutics, Merck to develop novel therapies for T2D, metabolic diseases May 3, 2013 CenterWatch Staff
Soligenix, Intrexon pursue melioidosis therapy through exclusive collaboration May 3, 2013 CenterWatch Staff
Bio-Optronics, Schulman Associates IRB to simplify clinical trial management May 3, 2013 CenterWatch Staff
Raptor Pharma's Procysbi receives FDA approval for nephropathic cystinosis May 3, 2013 CenterWatch Staff
Investigative sites rate INC Research, PPD, inVentiv top CROs in new CenterWatch study May 1, 2013 CenterWatch Staff